沙利度胺与地塞米松：多发性骨髓瘤初始治疗的新护理标准 - Suppr

Suppr

超能文献

Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma.

作者信息

Richardson Paul, Anderson Kenneth

出版信息

J Clin Oncol. 2006 Jan 20;24(3):334-6. doi: 10.1200/JCO.2005.03.8851. Epub 2005 Dec 19.

DOI:10.1200/JCO.2005.03.8851

PMID:16365174

Abstract

摘要

相似文献

Thalidomide and dexamethasone: a new standard of care for initial therapy in multiple myeloma.

J Clin Oncol. 2006 Jan 20;24(3):334-6. doi: 10.1200/JCO.2005.03.8851. Epub 2005 Dec 19.

[New treatment strategies for multiple myeloma].

Rinsho Ketsueki. 2009 Oct;50(10):1506-17.

Controversies regarding the use of dexamethasone in patients with multiple myeloma.

Clin Adv Hematol Oncol. 2008 Feb;6(2):103, 141.

Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.

Am J Hematol. 2007 Dec;82(12):1071-5. doi: 10.1002/ajh.21038.

The emperor's new clothes or the current practice of clinical trials for multiple myeloma in the USA.

Cancer Invest. 2008 Jun;26(5):445-7. doi: 10.1080/07357900701874641.

Refractory multiple myeloma treated with homoharringtonine: report of two cases.

Ann Hematol. 2007 Dec;86(12):919-21. doi: 10.1007/s00277-007-0331-5. Epub 2007 Jul 20.

Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience.

Ann Hematol. 2011 Jan;90(1):115-6. doi: 10.1007/s00277-010-0967-4. Epub 2010 Apr 27.

Thalidomide-dexamethasone plus pegylated liposomal doxorubicin vs. thalidomide-dexamethasone: a case-matched study in advanced multiple myeloma.

Eur J Haematol. 2007 Apr;78(4):297-302. doi: 10.1111/j.1600-0609.2007.00823.x. Epub 2007 Feb 5.

Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma.

Br J Haematol. 2006 Jan;132(2):155-61. doi: 10.1111/j.1365-2141.2005.05848.x.

Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma.

Am J Hematol. 2005 Jul;79(3):194-7. doi: 10.1002/ajh.20382.

引用本文的文献

Old drugs, new challenges: reassigning drugs for cancer therapies.

Cell Mol Biol Lett. 2025 Mar 5;30(1):27. doi: 10.1186/s11658-025-00710-0.

Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms.

Front Immunol. 2022 Oct 12;13:1017990. doi: 10.3389/fimmu.2022.1017990. eCollection 2022.

Response and Survival Estimates of Patients With Plasma Cell Myeloma in a Resource-Constrained Setting Using Protocols From High-Income Countries: A Single-Center Experience From Sri Lanka.

JCO Glob Oncol. 2022 Jun;8:e2100352. doi: 10.1200/GO.21.00352.

Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing.

Med Sci (Basel). 2022 Feb 18;10(1):15. doi: 10.3390/medsci10010015.

Cyclophosphamide, Thalidomide, and Dexamethasone as Initial Therapy for Patients With Newly Diagnosed Multiple Myeloma in a Middle-Income Country: 7-Year Follow-Up.

JCO Glob Oncol. 2021 Jul;7:1199-1205. doi: 10.1200/GO.20.00665.

Overcoming cancer therapeutic bottleneck by drug repurposing.

Signal Transduct Target Ther. 2020 Jul 2;5(1):113. doi: 10.1038/s41392-020-00213-8.

Therapeutic effects of thalidomide in hematologic disorders: a review.

Front Med. 2013 Sep;7(3):290-300. doi: 10.1007/s11684-013-0277-z. Epub 2013 Jul 15.

Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo.

Br J Haematol. 2010 May;149(4):537-49. doi: 10.1111/j.1365-2141.2010.08127.x. Epub 2010 Mar 12.

Peripheral neuropathy associated with novel therapies in patients with multiple myeloma: consensus statement of the IMF Nurse Leadership Board.

Clin J Oncol Nurs. 2008 Jun;12(3 Suppl):29-36. doi: 10.1188/08.CJON.S1.29-35.

Management of side effects of novel therapies for multiple myeloma: consensus statements developed by the International Myeloma Foundation's Nurse Leadership Board.

Clin J Oncol Nurs. 2008 Jun;12(3 Suppl):9-12. doi: 10.1188/08.CJON.S1.9-12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验